Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/25444
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDevecioǧlu, Ömer-
dc.contributor.authorErtem, M.-
dc.contributor.authorVergin, Canan-
dc.contributor.authorKavaklı, Kaan-
dc.contributor.authorCanatan, D.-
dc.contributor.authorToksoy, Hayri-
dc.contributor.authorYıldız, İnci-
dc.contributor.authorKürekçi, Emin-
dc.contributor.authorÖzgen, Ünsal-
dc.contributor.authorÖniz, Haldun-
dc.contributor.authorGürgey, Aytemiz-
dc.contributor.authorÖren, Hale-
dc.date.accessioned2022-03-30T10:35:05Z-
dc.date.available2022-03-30T10:35:05Z-
dc.date.issued2004-
dc.identifier.citationÖren, H. vd. (2004). “Analysis of pediatric thrombotic patients in Turkey”. Pediatric Hematology and Oncology, 21(7), 573-583.en_US
dc.identifier.issn0888-0018-
dc.identifier.urihttps://doi.org/10.1080/08880010490500935-
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.1080/08880010490500935-
dc.identifier.urihttp://hdl.handle.net/11452/25444-
dc.description.abstractThis study analyzes the data of thrombotic children who were followed up in different pediatric referral centers of Turkey, to obtain more general data on the diagnosis, risk factors, management, and outcome of thrombosis in Turkish children. A simple two-page questionnaire was distributed among contact people from each center to standardize data collection. Thirteen pediatric referral centers responded to the invitation and the total number of cases was 271. All children were diagnosed with thromboembolic disease between January 1995 and October 2001. Median age at time of first thrombotic event was 7.0 years. Of the children 4% of the cases were neonates, 12% were infants less than 1 year old, and 17% were adolescents. Thromboembolic event was mostly located in the cerebral vascular system (32%), deep venous system of the limbs, femoral and iliac veins (24%), portal veins (10%), and intracardiac region (9%). Acquired risk factors were present in 86% of the children. Infection was the most common underlying risk factor. Inherited risk factors were present in 30% of the children. FVL was the most common inherited risk factor. Acquired and inherited risk factors were present simultaneously in 19% of the patients. Eleven children had a history of familial thrombosis. Due to the local treatment preferences, the treatment of the children varied greatly. Outcome of the 142 patients (52%) was reported: 88 (62%) patients had complete resolution, 47 (33%) had complications, 12 (9%) had recurrent thrombosis, and 34 (24%) died. Three children (2.1%) died as a direct consequence of their thromboembolic disease. The significant morbidity and mortality found in this study supports the need for multicentric prospective clinical trials to obtain more generalizable data on management and outcome of thrombosis in Turkish children.en_US
dc.language.isoenen_US
dc.publisherTaylor & Francisen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOncologyen_US
dc.subjectHematologyen_US
dc.subjectPediatricsen_US
dc.subjectChildhooden_US
dc.subjectThromboembolismen_US
dc.subjectThrombosisen_US
dc.subjectVenous thromboembolic complicationsen_US
dc.subjectMolecular-weight heparinen_US
dc.subjectV-leiden mutationen_US
dc.subjectRisk-factorsen_US
dc.subjectChildrenen_US
dc.subjectDiseaseen_US
dc.subjectThrombophiliaen_US
dc.subjectHemostasisen_US
dc.subjectDiagnosisen_US
dc.subjectTherapyen_US
dc.subject.meshChilden_US
dc.subject.meshHumansen_US
dc.subject.meshMutationen_US
dc.subject.meshThromboembolismen_US
dc.subject.meshThrombosisen_US
dc.subject.meshTurkeyen_US
dc.titleAnalysis of pediatric thrombotic patients in Turkeyen_US
dc.typeArticleen_US
dc.identifier.wos000223843200001tr_TR
dc.identifier.scopus2-s2.0-5044234800tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı.tr_TR
dc.identifier.startpage573tr_TR
dc.identifier.endpage583tr_TR
dc.identifier.volume21tr_TR
dc.identifier.issue7tr_TR
dc.relation.journalPediatric Hematology and Oncologyen_US
dc.contributor.buuauthorMeral, Adalet-
dc.relation.collaborationYurt içitr_TR
dc.identifier.pubmed15626013tr_TR
dc.subject.wosOncologyen_US
dc.subject.wosHematologyen_US
dc.subject.wosPediatricsen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ4en_US
dc.contributor.scopusid6602571317tr_TR
dc.subject.scopusVenous Thromboembolism; Pediatrics; Thrombosisen_US
dc.subject.emtreeAntithrombin IIIen_US
dc.subject.emtreeBlood clotting factor 5 Leidenen_US
dc.subject.emtreeHeparinen_US
dc.subject.emtreeLow molecular weight heparinen_US
dc.subject.emtreeProtein Cen_US
dc.subject.emtreeProtein Sen_US
dc.subject.emtreeStreptokinaseen_US
dc.subject.emtreeTissue plasminogen activatoren_US
dc.subject.emtreeUrokinaseen_US
dc.subject.emtreeWarfarinen_US
dc.subject.emtreeAdolescenten_US
dc.subject.emtreeArteriovenous fistulaen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeAtaxiaen_US
dc.subject.emtreeAtrophyen_US
dc.subject.emtreeBrain blood vesselen_US
dc.subject.emtreeChilden_US
dc.subject.emtreeDeep vein thrombosisen_US
dc.subject.emtreeEpilepsyen_US
dc.subject.emtreeFemoral arteryen_US
dc.subject.emtreeFemoral veinen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeFulminating purpuraen_US
dc.subject.emtreeHepatic arteryen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeIliac arteryen_US
dc.subject.emtreeIliac veinen_US
dc.subject.emtreeInfanten_US
dc.subject.emtreeInfectionen_US
dc.subject.emtreeInformation processingen_US
dc.subject.emtreeIntracardiac thrombosisen_US
dc.subject.emtreeKidney atrophyen_US
dc.subject.emtreeKidney vein thrombosisen_US
dc.subject.emtreeLimb amputationen_US
dc.subject.emtreeLimb injuryen_US
dc.subject.emtreeLiver dysfunctionen_US
dc.subject.emtreeLiver vein thrombosisen_US
dc.subject.emtreeLung diseaseen_US
dc.subject.emtreeLung embolismen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMesenteric vein thrombosisen_US
dc.subject.emtreeMortalityen_US
dc.subject.emtreeMotor dysfunctionen_US
dc.subject.emtreeNewbornen_US
dc.subject.emtreeOcclusive cerebrovascular diseaseen_US
dc.subject.emtreePortal hypertensionen_US
dc.subject.emtreePortal vein thrombosisen_US
dc.subject.emtreeQuestionnaireen_US
dc.subject.emtreeRecurrent diseaseen_US
dc.subject.emtreeRetina arteryen_US
dc.subject.emtreeRisk factoren_US
dc.subject.emtreeSplenic veinen_US
dc.subject.emtreeThromboembolismen_US
dc.subject.emtreeThrombosisen_US
dc.subject.emtreeTimeen_US
dc.subject.emtreeTreatment outcomeen_US
dc.subject.emtreeTremoren_US
dc.subject.emtreeTurkey (Republic)en_US
dc.subject.emtreeVenuleen_US
dc.subject.emtreeVisual impairmenten_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.